市場調査レポート
商品コード
1410278

細胞膜透過ペプチドの世界市場規模、シェア、動向分析レポート：最終用途別、用途別、タイプ別、地域別展望および予測、2023年～2030年

Global Cell Penetrating Peptide Market Size, Share & Trends Analysis Report By End-use, By Application (Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging, and Others), By Type, By Regional Outlook and Forecast, 2023 - 2030
表紙：細胞膜透過ペプチドの世界市場規模、シェア、動向分析レポート：最終用途別、用途別、タイプ別、地域別展望および予測、2023年～2030年

出版日
発行
KBV Research
ページ情報
英文 239 Pages
納期
即納可能
細胞膜透過ペプチドの世界市場規模、シェア、動向分析レポート：最終用途別、用途別、タイプ別、地域別展望および予測、2023年～2030年
出版日: 2024年01月12日
発行: KBV Research
ページ情報: 英文 239 Pages
納期: 即納可能
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

細胞膜透過ペプチド市場規模は2030年までに27億米ドルに達し、予測期間中にCAGR 10.5%の市場成長率で上昇すると予測されています。

しかし、CPPは、エンドサイトーシス、直接移動、その他の経路など、様々な細胞取り込みメカニズムを利用しています。メカニズムの多様性は、CPPの細胞内への取り込みを研究する上で複雑さを増します。異なるCPPは、その物理化学的特性、細胞のタイプ、その他の要因に基づいて、異なる経路を用いる可能性があります。この多様性を理解することは、CPPを特定の治療用途に適合させるために極めて重要です。細胞が細胞外物質を取り込むエンドサイトーシスは、CPPの内在化の主要な経路です。したがって、これらの側面は、今後数年間、細胞膜透過ペプチドの需要を減少させると思われます。

さらに、パンデミックは研究の優先順位と資金配分の大幅な再編成を促し、COVID-19関連の研究と治療薬への重点が高まった。以前はCPP研究を含む多様な分野に向けられていた資源が、パンデミックの緊急ニーズに対応するために振り向けられました。CPP関連を含む多くの研究プロジェクトは、研究室での作業の中断、研究施設への物理的なアクセスの制限、研究努力の再優先順位付けなどにより、遅れに直面しました。そのため、COVID-19パンデミックは市場に悪影響を与えました。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場要覧

  • 主なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因
  • ポーターのファイブフォース分析

第4章 世界市場：最終用途別

  • 世界の製薬およびバイオテクノロジー企業市場：地域別
  • 世界の受託調査機関（CRO）市場：地域別
  • 世界の病院およびクリニック市場：地域別
  • 世界のその他の市場：地域別

第5章 世界市場：用途別

  • 世界のドラッグデリバリー市場：地域別
  • 世界の遺伝子デリバリー市場：地域別
  • 世界の診断市場：地域別
  • 世界の分子イメージング市場：地域別
  • 世界のその他の市場：地域別

第6章 世界市場：タイプ別

  • 世界の合成CPP市場：地域別
  • 世界のタンパク質由来CPP市場：地域別
  • 世界のキメラCPP市場：地域別

第7章 世界市場：地域別

  • 北米の市場
    • 最終用途別
    • 用途別
    • タイプ別
    • 国別
      • 米国の細胞膜透過ペプチド市場
      • カナダの細胞膜透過ペプチド市場
      • メキシコの細胞膜透過ペプチド市場
      • その他北米の市場
  • 欧州の市場
    • 最終用途別
    • 用途別
    • タイプ別
    • 国別
      • ドイツの細胞膜透過ペプチド市場
      • 英国の細胞膜透過ペプチド市場
      • フランスの細胞膜透過ペプチド市場
      • ロシアの細胞膜透過ペプチド市場
      • スペインの細胞膜透過ペプチド市場
      • イタリアの細胞膜透過ペプチド市場
      • その他欧州の市場
  • アジア太平洋の市場
    • 最終用途別
    • 用途別
    • タイプ別
    • 国別
      • 中国の細胞膜透過ペプチド市場
      • 日本の細胞膜透過ペプチド市場
      • インドの細胞膜透過ペプチド市場
      • 韓国の細胞膜透過ペプチド市場
      • 台湾の細胞膜透過ペプチド市場
      • マレーシアの細胞膜透過ペプチド市場
      • その他アジア太平洋の市場
  • ラテンアメリカ・中東・アフリカの市場
    • 最終用途別
    • 用途別
    • タイプ別
    • 国別
      • ブラジルの細胞膜透過ペプチド市場
      • アルゼンチンの細胞膜透過ペプチド市場
      • UAEの細胞膜透過ペプチド市場
      • サウジアラビアの細胞膜透過ペプチド市場
      • 南アフリカの細胞膜透過ペプチド市場
      • ナイジェリアの細胞膜透過ペプチド市場
      • その他ラテンアメリカ・中東・アフリカの市場

第8章 企業プロファイル

  • Biosynth Ltd
  • Creative Peptides
  • Cupid Peptide Company Limited
  • Alta Bioscience Ltd
  • AnaSpec Inc（Kaneka Eurogentec S.A.）（Kaneka Corporation）
  • Peptomyc SL
  • PolyPeptide Group AG
  • Bachem Holding AG（Ingro Finanz AG）
  • Sarepta Therapeutics, Inc
  • Revance Therapeutics, Inc

第9章 細胞膜透過ペプチド市場の成功必須条件

図表

LIST OF TABLES

  • TABLE 1 Global Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 2 Global Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 3 Global Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 4 Global Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 5 Global Pharmaceutical and Biotechnology Companies Market, by Region, 2019 - 2022, USD Million
  • TABLE 6 Global Pharmaceutical and Biotechnology Companies Market, by Region, 2023 - 2030, USD Million
  • TABLE 7 Global Contract Research Organization (CROs) Market, by Region, 2019 - 2022, USD Million
  • TABLE 8 Global Contract Research Organization (CROs) Market, by Region, 2023 - 2030, USD Million
  • TABLE 9 Global Hospitals & Clinics Market, by Region, 2019 - 2022, USD Million
  • TABLE 10 Global Hospitals & Clinics Market, by Region, 2023 - 2030, USD Million
  • TABLE 11 Global Others Market, by Region, 2019 - 2022, USD Million
  • TABLE 12 Global Others Market, by Region, 2023 - 2030, USD Million
  • TABLE 13 Global Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 14 Global Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 15 Global Drug Delivery Market, by Region, 2019 - 2022, USD Million
  • TABLE 16 Global Drug Delivery Market, by Region, 2023 - 2030, USD Million
  • TABLE 17 Global Gene Delivery Market, by Region, 2019 - 2022, USD Million
  • TABLE 18 Global Gene Delivery Market, by Region, 2023 - 2030, USD Million
  • TABLE 19 Global Diagnostics Market, by Region, 2019 - 2022, USD Million
  • TABLE 20 Global Diagnostics Market, by Region, 2023 - 2030, USD Million
  • TABLE 21 Global Molecular Imaging Market, by Region, 2019 - 2022, USD Million
  • TABLE 22 Global Molecular Imaging Market, by Region, 2023 - 2030, USD Million
  • TABLE 23 Global Others Market, by Region, 2019 - 2022, USD Million
  • TABLE 24 Global Others Market, by Region, 2023 - 2030, USD Million
  • TABLE 25 Global Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 26 Global Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 27 Global Synthetic CPPs Market, by Region, 2019 - 2022, USD Million
  • TABLE 28 Global Synthetic CPPs Market, by Region, 2023 - 2030, USD Million
  • TABLE 29 Global Protein-derived CPPs Market, by Region, 2019 - 2022, USD Million
  • TABLE 30 Global Protein-derived CPPs Market, by Region, 2023 - 2030, USD Million
  • TABLE 31 Global Chimeric CPPs Market, by Region, 2019 - 2022, USD Million
  • TABLE 32 Global Chimeric CPPs Market, by Region, 2023 - 2030, USD Million
  • TABLE 33 Global Cell Penetrating Peptide Market, by Region, 2019 - 2022, USD Million
  • TABLE 34 Global Cell Penetrating Peptide Market, by Region, 2023 - 2030, USD Million
  • TABLE 35 North America Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 36 North America Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 37 North America Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 38 North America Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 39 North America Pharmaceutical and Biotechnology Companies Market, by Country, 2019 - 2022, USD Million
  • TABLE 40 North America Pharmaceutical and Biotechnology Companies Market, by Country, 2023 - 2030, USD Million
  • TABLE 41 North America Contract Research Organization (CROs) Market, by Country, 2019 - 2022, USD Million
  • TABLE 42 North America Contract Research Organization (CROs) Market, by Country, 2023 - 2030, USD Million
  • TABLE 43 North America Hospitals & Clinics Market, by Country, 2019 - 2022, USD Million
  • TABLE 44 North America Hospitals & Clinics Market, by Country, 2023 - 2030, USD Million
  • TABLE 45 North America Others Market, by Country, 2019 - 2022, USD Million
  • TABLE 46 North America Others Market, by Country, 2023 - 2030, USD Million
  • TABLE 47 North America Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 48 North America Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 49 North America Drug Delivery Market, by Country, 2019 - 2022, USD Million
  • TABLE 50 North America Drug Delivery Market, by Country, 2023 - 2030, USD Million
  • TABLE 51 North America Gene Delivery Market, by Country, 2019 - 2022, USD Million
  • TABLE 52 North America Gene Delivery Market, by Country, 2023 - 2030, USD Million
  • TABLE 53 North America Diagnostics Market, by Country, 2019 - 2022, USD Million
  • TABLE 54 North America Diagnostics Market, by Country, 2023 - 2030, USD Million
  • TABLE 55 North America Molecular Imaging Market, by Country, 2019 - 2022, USD Million
  • TABLE 56 North America Molecular Imaging Market, by Country, 2023 - 2030, USD Million
  • TABLE 57 North America Others Market, by Country, 2019 - 2022, USD Million
  • TABLE 58 North America Others Market, by Country, 2023 - 2030, USD Million
  • TABLE 59 North America Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 60 North America Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 61 North America Synthetic CPPs Market, by Country, 2019 - 2022, USD Million
  • TABLE 62 North America Synthetic CPPs Market, by Country, 2023 - 2030, USD Million
  • TABLE 63 North America Protein-derived CPPs Market, by Country, 2019 - 2022, USD Million
  • TABLE 64 North America Protein-derived CPPs Market, by Country, 2023 - 2030, USD Million
  • TABLE 65 North America Chimeric CPPs Market, by Country, 2019 - 2022, USD Million
  • TABLE 66 North America Chimeric CPPs Market, by Country, 2023 - 2030, USD Million
  • TABLE 67 North America Cell Penetrating Peptide Market, by Country, 2019 - 2022, USD Million
  • TABLE 68 North America Cell Penetrating Peptide Market, by Country, 2023 - 2030, USD Million
  • TABLE 69 US Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 70 US Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 71 US Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 72 US Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 73 US Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 74 US Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 75 US Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 76 US Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 77 Canada Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 78 Canada Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 79 Canada Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 80 Canada Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 81 Canada Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 82 Canada Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 83 Canada Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 84 Canada Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 85 Mexico Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 86 Mexico Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 87 Mexico Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 88 Mexico Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 89 Mexico Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 90 Mexico Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 91 Mexico Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 92 Mexico Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 93 Rest of North America Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 94 Rest of North America Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 95 Rest of North America Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 96 Rest of North America Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 97 Rest of North America Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 98 Rest of North America Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 99 Rest of North America Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 100 Rest of North America Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 101 Europe Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 102 Europe Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 103 Europe Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 104 Europe Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 105 Europe Pharmaceutical and Biotechnology Companies Market, by Country, 2019 - 2022, USD Million
  • TABLE 106 Europe Pharmaceutical and Biotechnology Companies Market, by Country, 2023 - 2030, USD Million
  • TABLE 107 Europe Contract Research Organization (CROs) Market, by Country, 2019 - 2022, USD Million
  • TABLE 108 Europe Contract Research Organization (CROs) Market, by Country, 2023 - 2030, USD Million
  • TABLE 109 Europe Hospitals & Clinics Market, by Country, 2019 - 2022, USD Million
  • TABLE 110 Europe Hospitals & Clinics Market, by Country, 2023 - 2030, USD Million
  • TABLE 111 Europe Others Market, by Country, 2019 - 2022, USD Million
  • TABLE 112 Europe Others Market, by Country, 2023 - 2030, USD Million
  • TABLE 113 Europe Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 114 Europe Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 115 Europe Drug Delivery Market, by Country, 2019 - 2022, USD Million
  • TABLE 116 Europe Drug Delivery Market, by Country, 2023 - 2030, USD Million
  • TABLE 117 Europe Gene Delivery Market, by Country, 2019 - 2022, USD Million
  • TABLE 118 Europe Gene Delivery Market, by Country, 2023 - 2030, USD Million
  • TABLE 119 Europe Diagnostics Market, by Country, 2019 - 2022, USD Million
  • TABLE 120 Europe Diagnostics Market, by Country, 2023 - 2030, USD Million
  • TABLE 121 Europe Molecular Imaging Market, by Country, 2019 - 2022, USD Million
  • TABLE 122 Europe Molecular Imaging Market, by Country, 2023 - 2030, USD Million
  • TABLE 123 Europe Others Market, by Country, 2019 - 2022, USD Million
  • TABLE 124 Europe Others Market, by Country, 2023 - 2030, USD Million
  • TABLE 125 Europe Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 126 Europe Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 127 Europe Synthetic CPPs Market, by Country, 2019 - 2022, USD Million
  • TABLE 128 Europe Synthetic CPPs Market, by Country, 2023 - 2030, USD Million
  • TABLE 129 Europe Protein-derived CPPs Market, by Country, 2019 - 2022, USD Million
  • TABLE 130 Europe Protein-derived CPPs Market, by Country, 2023 - 2030, USD Million
  • TABLE 131 Europe Chimeric CPPs Market, by Country, 2019 - 2022, USD Million
  • TABLE 132 Europe Chimeric CPPs Market, by Country, 2023 - 2030, USD Million
  • TABLE 133 Europe Cell Penetrating Peptide Market, by Country, 2019 - 2022, USD Million
  • TABLE 134 Europe Cell Penetrating Peptide Market, by Country, 2023 - 2030, USD Million
  • TABLE 135 Germany Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 136 Germany Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 137 Germany Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 138 Germany Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 139 Germany Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 140 Germany Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 141 Germany Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 142 Germany Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 143 UK Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 144 UK Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 145 UK Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 146 UK Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 147 UK Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 148 UK Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 149 UK Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 150 UK Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 151 France Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 152 France Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 153 France Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 154 France Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 155 France Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 156 France Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 157 France Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 158 France Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 159 Russia Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 160 Russia Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 161 Russia Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 162 Russia Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 163 Russia Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 164 Russia Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 165 Russia Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 166 Russia Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 167 Spain Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 168 Spain Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 169 Spain Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 170 Spain Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 171 Spain Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 172 Spain Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 173 Spain Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 174 Spain Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 175 Italy Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 176 Italy Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 177 Italy Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 178 Italy Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 179 Italy Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 180 Italy Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 181 Italy Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 182 Italy Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 183 Rest of Europe Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 184 Rest of Europe Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 185 Rest of Europe Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 186 Rest of Europe Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 187 Rest of Europe Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 188 Rest of Europe Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 189 Rest of Europe Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 190 Rest of Europe Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 191 Asia Pacific Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 192 Asia Pacific Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 193 Asia Pacific Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 194 Asia Pacific Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 195 Asia Pacific Pharmaceutical and Biotechnology Companies Market, by Country, 2019 - 2022, USD Million
  • TABLE 196 Asia Pacific Pharmaceutical and Biotechnology Companies Market, by Country, 2023 - 2030, USD Million
  • TABLE 197 Asia Pacific Contract Research Organization (CROs) Market, by Country, 2019 - 2022, USD Million
  • TABLE 198 Asia Pacific Contract Research Organization (CROs) Market, by Country, 2023 - 2030, USD Million
  • TABLE 199 Asia Pacific Hospitals & Clinics Market, by Country, 2019 - 2022, USD Million
  • TABLE 200 Asia Pacific Hospitals & Clinics Market, by Country, 2023 - 2030, USD Million
  • TABLE 201 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
  • TABLE 202 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
  • TABLE 203 Asia Pacific Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 204 Asia Pacific Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 205 Asia Pacific Drug Delivery Market, by Country, 2019 - 2022, USD Million
  • TABLE 206 Asia Pacific Drug Delivery Market, by Country, 2023 - 2030, USD Million
  • TABLE 207 Asia Pacific Gene Delivery Market, by Country, 2019 - 2022, USD Million
  • TABLE 208 Asia Pacific Gene Delivery Market, by Country, 2023 - 2030, USD Million
  • TABLE 209 Asia Pacific Diagnostics Market, by Country, 2019 - 2022, USD Million
  • TABLE 210 Asia Pacific Diagnostics Market, by Country, 2023 - 2030, USD Million
  • TABLE 211 Asia Pacific Molecular Imaging Market, by Country, 2019 - 2022, USD Million
  • TABLE 212 Asia Pacific Molecular Imaging Market, by Country, 2023 - 2030, USD Million
  • TABLE 213 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
  • TABLE 214 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
  • TABLE 215 Asia Pacific Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 216 Asia Pacific Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 217 Asia Pacific Synthetic CPPs Market, by Country, 2019 - 2022, USD Million
  • TABLE 218 Asia Pacific Synthetic CPPs Market, by Country, 2023 - 2030, USD Million
  • TABLE 219 Asia Pacific Protein-derived CPPs Market, by Country, 2019 - 2022, USD Million
  • TABLE 220 Asia Pacific Protein-derived CPPs Market, by Country, 2023 - 2030, USD Million
  • TABLE 221 Asia Pacific Chimeric CPPs Market, by Country, 2019 - 2022, USD Million
  • TABLE 222 Asia Pacific Chimeric CPPs Market, by Country, 2023 - 2030, USD Million
  • TABLE 223 Asia Pacific Cell Penetrating Peptide Market, by Country, 2019 - 2022, USD Million
  • TABLE 224 Asia Pacific Cell Penetrating Peptide Market, by Country, 2023 - 2030, USD Million
  • TABLE 225 China Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 226 China Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 227 China Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 228 China Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 229 China Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 230 China Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 231 China Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 232 China Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 233 Japan Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 234 Japan Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 235 Japan Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 236 Japan Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 237 Japan Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 238 Japan Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 239 Japan Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 240 Japan Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 241 India Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 242 India Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 243 India Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 244 India Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 245 India Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 246 India Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 247 India Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 248 India Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 249 South Korea Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 250 South Korea Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 251 South Korea Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 252 South Korea Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 253 South Korea Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 254 South Korea Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 255 South Korea Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 256 South Korea Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 257 Taiwan Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 258 Taiwan Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 259 Taiwan Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 260 Taiwan Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 261 Taiwan Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 262 Taiwan Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 263 Taiwan Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 264 Taiwan Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 265 Malaysia Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 266 Malaysia Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 267 Malaysia Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 268 Malaysia Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 269 Malaysia Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 270 Malaysia Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 271 Malaysia Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 272 Malaysia Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 273 Rest of Asia Pacific Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 274 Rest of Asia Pacific Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 275 Rest of Asia Pacific Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 276 Rest of Asia Pacific Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 277 Rest of Asia Pacific Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 278 Rest of Asia Pacific Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 279 Rest of Asia Pacific Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 280 Rest of Asia Pacific Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 281 LAMEA Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 282 LAMEA Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 283 LAMEA Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 284 LAMEA Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 285 LAMEA Pharmaceutical and Biotechnology Companies Market, by Country, 2019 - 2022, USD Million
  • TABLE 286 LAMEA Pharmaceutical and Biotechnology Companies Market, by Country, 2023 - 2030, USD Million
  • TABLE 287 LAMEA Contract Research Organization (CROs) Market, by Country, 2019 - 2022, USD Million
  • TABLE 288 LAMEA Contract Research Organization (CROs) Market, by Country, 2023 - 2030, USD Million
  • TABLE 289 LAMEA Hospitals & Clinics Market, by Country, 2019 - 2022, USD Million
  • TABLE 290 LAMEA Hospitals & Clinics Market, by Country, 2023 - 2030, USD Million
  • TABLE 291 LAMEA Others Market, by Country, 2019 - 2022, USD Million
  • TABLE 292 LAMEA Others Market, by Country, 2023 - 2030, USD Million
  • TABLE 293 LAMEA Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 294 LAMEA Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 295 LAMEA Drug Delivery Market, by Country, 2019 - 2022, USD Million
  • TABLE 296 LAMEA Drug Delivery Market, by Country, 2023 - 2030, USD Million
  • TABLE 297 LAMEA Gene Delivery Market, by Country, 2019 - 2022, USD Million
  • TABLE 298 LAMEA Gene Delivery Market, by Country, 2023 - 2030, USD Million
  • TABLE 299 LAMEA Diagnostics Market, by Country, 2019 - 2022, USD Million
  • TABLE 300 LAMEA Diagnostics Market, by Country, 2023 - 2030, USD Million
  • TABLE 301 LAMEA Molecular Imaging Market, by Country, 2019 - 2022, USD Million
  • TABLE 302 LAMEA Molecular Imaging Market, by Country, 2023 - 2030, USD Million
  • TABLE 303 LAMEA Others Market, by Country, 2019 - 2022, USD Million
  • TABLE 304 LAMEA Others Market, by Country, 2023 - 2030, USD Million
  • TABLE 305 LAMEA Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 306 LAMEA Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 307 LAMEA Synthetic CPPs Market, by Country, 2019 - 2022, USD Million
  • TABLE 308 LAMEA Synthetic CPPs Market, by Country, 2023 - 2030, USD Million
  • TABLE 309 LAMEA Protein-derived CPPs Market, by Country, 2019 - 2022, USD Million
  • TABLE 310 LAMEA Protein-derived CPPs Market, by Country, 2023 - 2030, USD Million
  • TABLE 311 LAMEA Chimeric CPPs Market, by Country, 2019 - 2022, USD Million
  • TABLE 312 LAMEA Chimeric CPPs Market, by Country, 2023 - 2030, USD Million
  • TABLE 313 LAMEA Cell Penetrating Peptide Market, by Country, 2019 - 2022, USD Million
  • TABLE 314 LAMEA Cell Penetrating Peptide Market, by Country, 2023 - 2030, USD Million
  • TABLE 315 Brazil Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 316 Brazil Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 317 Brazil Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 318 Brazil Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 319 Brazil Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 320 Brazil Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 321 Brazil Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 322 Brazil Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 323 Argentina Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 324 Argentina Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 325 Argentina Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 326 Argentina Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 327 Argentina Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 328 Argentina Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 329 Argentina Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 330 Argentina Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 331 UAE Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 332 UAE Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 333 UAE Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 334 UAE Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 335 UAE Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 336 UAE Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 337 UAE Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 338 UAE Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 339 Saudi Arabia Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 340 Saudi Arabia Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 341 Saudi Arabia Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 342 Saudi Arabia Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 343 Saudi Arabia Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 344 Saudi Arabia Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 345 Saudi Arabia Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 346 Saudi Arabia Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 347 South Africa Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 348 South Africa Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 349 South Africa Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 350 South Africa Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 351 South Africa Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 352 South Africa Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 353 South Africa Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 354 South Africa Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 355 Nigeria Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 356 Nigeria Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 357 Nigeria Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 358 Nigeria Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 359 Nigeria Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 360 Nigeria Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 361 Nigeria Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 362 Nigeria Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 363 Rest of LAMEA Cell Penetrating Peptide Market, 2019 - 2022, USD Million
  • TABLE 364 Rest of LAMEA Cell Penetrating Peptide Market, 2023 - 2030, USD Million
  • TABLE 365 Rest of LAMEA Cell Penetrating Peptide Market, by End-use, 2019 - 2022, USD Million
  • TABLE 366 Rest of LAMEA Cell Penetrating Peptide Market, by End-use, 2023 - 2030, USD Million
  • TABLE 367 Rest of LAMEA Cell Penetrating Peptide Market, by Application, 2019 - 2022, USD Million
  • TABLE 368 Rest of LAMEA Cell Penetrating Peptide Market, by Application, 2023 - 2030, USD Million
  • TABLE 369 Rest of LAMEA Cell Penetrating Peptide Market, by Type, 2019 - 2022, USD Million
  • TABLE 370 Rest of LAMEA Cell Penetrating Peptide Market, by Type, 2023 - 2030, USD Million
  • TABLE 371 Key Information - Biosynth Ltd
  • TABLE 372 Key Information - Creative Peptides
  • TABLE 373 Key Information - Cupid Peptide Company Limited
  • TABLE 374 Key Information - Alta Bioscience Ltd
  • TABLE 375 Key Information - AnaSpec Inc.
  • TABLE 376 Key Information - Peptomyc SL
  • TABLE 377 Key Information - PolyPeptide Group AG
  • TABLE 378 Key Information - Bachem Holding AG
  • TABLE 379 key information - Sarepta Therapeutics, Inc.
  • TABLE 380 Key information - Revance Therapeutics, Inc.
目次

The Global Cell Penetrating Peptide Market size is expected to reach $2.7 billion by 2030, rising at a market growth of 10.5% CAGR during the forecast period.

CPPs offer selectivity in drug delivery, allowing targeted delivery to specific cells or tissues. This targeted approach is advantageous as it minimizes the exposure of healthy cells to therapeutic agents, reducing off-target effects and potential side effects associated with non-specific drug distribution. Consequently, the Chimeric CPPs segment would generate approximately 7.65% share of the market by 2030. CPPs exhibit versatility in delivering various types of therapeutic cargo. They can transport small molecules, peptides, proteins, and nucleic acids, making them suitable for biomedical applications.

Peptide-based therapeutics have gained prominence as a class of drugs with unique properties. They offer specificity in targeting, which can enhance the precision of treatment, and are often associated with lower toxicity and reduced immunogenicity compared to some traditional drugs. This enhanced bioavailability contributes to the overall efficacy of peptide-based therapeutics. These factors will help in the expansion of the market. Moreover, CPPs are crucial in targeted drug delivery, addressing the need for precision in treating chronic diseases. By facilitating the transport of therapeutic agents across cell membranes, CPPs enhance the targeted delivery of drugs to specific cells or tissues affected by chronic conditions. In cancer therapy, CPPs have shown promise in delivering anticancer drugs directly to cancer cells. Thus, these factors will pose lucrative growth prospects for the market.

However, CPPs utilize various cellular uptake mechanisms, including endocytosis, direct translocation, and other pathways. The diversity of mechanisms adds complexity to studying CPP entry into cells. Different CPPs may employ different pathways based on their physicochemical properties, cell type, and other factors. Understanding this diversity is crucial for tailoring CPPs to specific therapeutic applications. Endocytosis, a process where cells engulf extracellular material, is a major pathway for CPP internalization. Therefore, these aspects will reduce demand for cell penetrating peptides in the upcoming years.

Further, the pandemic prompted a significant realignment of research priorities and funding allocations, with a heightened focus on COVID-19-related research and therapeutics. Resources previously directed toward diverse areas, including CPP research, were redirected to address the urgent needs of the pandemic. Many research projects, including those related to CPPs, faced delays due to disruptions in laboratory work, restrictions on physical access to research facilities, and the reprioritization of research efforts. Therefore, the COVID-19 pandemic adversely affected the market.

By End-Use Analysis

Based on end-use, the market is divided into pharmaceutical & biotechnology companies, contract research organizations (CROs), hospitals & clinics, and others. The pharmaceutical and biotechnology companies segment recorded the maximum revenue share in the market in 2022. The pharmaceutical and biotechnology sectors increasingly focus on developing targeted therapies to enhance treatment precision and reduce side effects. CPPs play a crucial role in this context by enabling the targeted delivery of therapeutic agents to specific cells or tissues. This targeted approach aligns with the growing trend of personalized medicine, where therapies are tailored to individual patient profiles. As a result, the segment will grow rapidly in the coming years.

By Application Analysis

On the basis of application, the market is divided into drug delivery, gene delivery, diagnostics, molecular imaging, and others. In 2022, the gene delivery segment witnessed a substantial revenue share in the market. Gene therapy has advanced considerably, with various diseases being treated at the genetic level. CPPs play an important role in gene therapy by acting as carriers for therapeutic genes. By transferring functional or therapeutic genes into target cells, this technique shows promise for treating genetic diseases, malignancies, and other ailments. These factors will assist in the expansion of the segment.

By Type Analysis

Based on type, the market is segmented into protein derived CPPs, synthetic CPPs, and chimeric CPPs. The synthetic CPPs segment held the largest revenue share in the market in 2022. Synthetic CPPs often exhibit enhanced stability compared to natural CPPs. The synthetic design allows for incorporating modifications that improve resistance to enzymatic degradation and enhance overall stability in physiological conditions. This increased stability contributes to improved bioavailability and sustained therapeutic effects, addressing challenges associated with the rapid degradation of peptides. These factors will boost the demand in the segment.

By Regional Analysis

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2022, the Europe segment acquired a considerable revenue share in the market. Europe has witnessed increased investments in biotechnology, which includes areas such as drug development and delivery technologies. The cell-penetrating peptide market has likely benefited from these investments, leading to advancements in research and the potential commercialization of CPP-based products. These aspects will fuel the expansion of the segment.

List of Key Companies Profiled

  • Biosynth Ltd
  • Creative Peptides
  • Cupid Peptide Company Limited
  • Alta Bioscience Ltd
  • AnaSpec Inc. (Kaneka Eurogentec S.A.) (Kaneka Corporation)
  • Peptomyc SL
  • PolyPeptide Group AG
  • Bachem Holding AG (Ingro Finanz AG)
  • Sarepta Therapeutics, Inc.
  • Revance Therapeutics, Inc.

Global Cell Penetrating Peptide Market Report Segmentation

By End-use

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organization (CROs)
  • Hospitals & Clinics
  • Others

By Application

  • Drug Delivery
  • Gene Delivery
  • Diagnostics
  • Molecular Imaging
  • Others

By Type

  • Synthetic CPPs
  • Protein-derived CPPs
  • Chimeric CPPs

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Cell Penetrating Peptide Market, by End-use
    • 1.4.2 Global Cell Penetrating Peptide Market, by Application
    • 1.4.3 Global Cell Penetrating Peptide Market, by Type
    • 1.4.4 Global Cell Penetrating Peptide Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Forces Analysis

Chapter 4. Global Cell Penetrating Peptide Market, by End-use

  • 4.1 Global Pharmaceutical and Biotechnology Companies Market, by Region
  • 4.2 Global Contract Research Organization (CROs) Market, by Region
  • 4.3 Global Hospitals & Clinics Market, by Region
  • 4.4 Global Others Market, by Region

Chapter 5. Global Cell Penetrating Peptide Market, by Application

  • 5.1 Global Drug Delivery Market, by Region
  • 5.2 Global Gene Delivery Market, by Region
  • 5.3 Global Diagnostics Market, by Region
  • 5.4 Global Molecular Imaging Market, by Region
  • 5.5 Global Others Market, by Region

Chapter 6. Global Cell Penetrating Peptide Market, by Type

  • 6.1 Global Synthetic CPPs Market, by Region
  • 6.2 Global Protein-derived CPPs Market, by Region
  • 6.3 Global Chimeric CPPs Market, by Region

Chapter 7. Global Cell Penetrating Peptide Market, by Region

  • 7.1 North America Cell Penetrating Peptide Market
    • 7.1.1 North America Cell Penetrating Peptide Market, by End-use
      • 7.1.1.1 North America Pharmaceutical and Biotechnology Companies Market, by Country
      • 7.1.1.2 North America Contract Research Organization (CROs) Market, by Country
      • 7.1.1.3 North America Hospitals & Clinics Market, by Country
      • 7.1.1.4 North America Others Market, by Country
    • 7.1.2 North America Cell Penetrating Peptide Market, by Application
      • 7.1.2.1 North America Drug Delivery Market, by Country
      • 7.1.2.2 North America Gene Delivery Market, by Country
      • 7.1.2.3 North America Diagnostics Market, by Country
      • 7.1.2.4 North America Molecular Imaging Market, by Country
      • 7.1.2.5 North America Others Market, by Country
    • 7.1.3 North America Cell Penetrating Peptide Market, by Type
      • 7.1.3.1 North America Synthetic CPPs Market, by Country
      • 7.1.3.2 North America Protein-derived CPPs Market, by Country
      • 7.1.3.3 North America Chimeric CPPs Market, by Country
    • 7.1.4 North America Cell Penetrating Peptide Market, by Country
      • 7.1.4.1 US Cell Penetrating Peptide Market
        • 7.1.4.1.1 US Cell Penetrating Peptide Market, by End-use
        • 7.1.4.1.2 US Cell Penetrating Peptide Market, by Application
        • 7.1.4.1.3 US Cell Penetrating Peptide Market, by Type
      • 7.1.4.2 Canada Cell Penetrating Peptide Market
        • 7.1.4.2.1 Canada Cell Penetrating Peptide Market, by End-use
        • 7.1.4.2.2 Canada Cell Penetrating Peptide Market, by Application
        • 7.1.4.2.3 Canada Cell Penetrating Peptide Market, by Type
      • 7.1.4.3 Mexico Cell Penetrating Peptide Market
        • 7.1.4.3.1 Mexico Cell Penetrating Peptide Market, by End-use
        • 7.1.4.3.2 Mexico Cell Penetrating Peptide Market, by Application
        • 7.1.4.3.3 Mexico Cell Penetrating Peptide Market, by Type
      • 7.1.4.4 Rest of North America Cell Penetrating Peptide Market
        • 7.1.4.4.1 Rest of North America Cell Penetrating Peptide Market, by End-use
        • 7.1.4.4.2 Rest of North America Cell Penetrating Peptide Market, by Application
        • 7.1.4.4.3 Rest of North America Cell Penetrating Peptide Market, by Type
  • 7.2 Europe Cell Penetrating Peptide Market
    • 7.2.1 Europe Cell Penetrating Peptide Market, by End-use
      • 7.2.1.1 Europe Pharmaceutical and Biotechnology Companies Market, by Country
      • 7.2.1.2 Europe Contract Research Organization (CROs) Market, by Country
      • 7.2.1.3 Europe Hospitals & Clinics Market, by Country
      • 7.2.1.4 Europe Others Market, by Country
    • 7.2.2 Europe Cell Penetrating Peptide Market, by Application
      • 7.2.2.1 Europe Drug Delivery Market, by Country
      • 7.2.2.2 Europe Gene Delivery Market, by Country
      • 7.2.2.3 Europe Diagnostics Market, by Country
      • 7.2.2.4 Europe Molecular Imaging Market, by Country
      • 7.2.2.5 Europe Others Market, by Country
    • 7.2.3 Europe Cell Penetrating Peptide Market, by Type
      • 7.2.3.1 Europe Synthetic CPPs Market, by Country
      • 7.2.3.2 Europe Protein-derived CPPs Market, by Country
      • 7.2.3.3 Europe Chimeric CPPs Market, by Country
    • 7.2.4 Europe Cell Penetrating Peptide Market, by Country
      • 7.2.4.1 Germany Cell Penetrating Peptide Market
        • 7.2.4.1.1 Germany Cell Penetrating Peptide Market, by End-use
        • 7.2.4.1.2 Germany Cell Penetrating Peptide Market, by Application
        • 7.2.4.1.3 Germany Cell Penetrating Peptide Market, by Type
      • 7.2.4.2 UK Cell Penetrating Peptide Market
        • 7.2.4.2.1 UK Cell Penetrating Peptide Market, by End-use
        • 7.2.4.2.2 UK Cell Penetrating Peptide Market, by Application
        • 7.2.4.2.3 UK Cell Penetrating Peptide Market, by Type
      • 7.2.4.3 France Cell Penetrating Peptide Market
        • 7.2.4.3.1 France Cell Penetrating Peptide Market, by End-use
        • 7.2.4.3.2 France Cell Penetrating Peptide Market, by Application
        • 7.2.4.3.3 France Cell Penetrating Peptide Market, by Type
      • 7.2.4.4 Russia Cell Penetrating Peptide Market
        • 7.2.4.4.1 Russia Cell Penetrating Peptide Market, by End-use
        • 7.2.4.4.2 Russia Cell Penetrating Peptide Market, by Application
        • 7.2.4.4.3 Russia Cell Penetrating Peptide Market, by Type
      • 7.2.4.5 Spain Cell Penetrating Peptide Market
        • 7.2.4.5.1 Spain Cell Penetrating Peptide Market, by End-use
        • 7.2.4.5.2 Spain Cell Penetrating Peptide Market, by Application
        • 7.2.4.5.3 Spain Cell Penetrating Peptide Market, by Type
      • 7.2.4.6 Italy Cell Penetrating Peptide Market
        • 7.2.4.6.1 Italy Cell Penetrating Peptide Market, by End-use
        • 7.2.4.6.2 Italy Cell Penetrating Peptide Market, by Application
        • 7.2.4.6.3 Italy Cell Penetrating Peptide Market, by Type
      • 7.2.4.7 Rest of Europe Cell Penetrating Peptide Market
        • 7.2.4.7.1 Rest of Europe Cell Penetrating Peptide Market, by End-use
        • 7.2.4.7.2 Rest of Europe Cell Penetrating Peptide Market, by Application
        • 7.2.4.7.3 Rest of Europe Cell Penetrating Peptide Market, by Type
  • 7.3 Asia Pacific Cell Penetrating Peptide Market
    • 7.3.1 Asia Pacific Cell Penetrating Peptide Market, by End-use
      • 7.3.1.1 Asia Pacific Pharmaceutical and Biotechnology Companies Market, by Country
      • 7.3.1.2 Asia Pacific Contract Research Organization (CROs) Market, by Country
      • 7.3.1.3 Asia Pacific Hospitals & Clinics Market, by Country
      • 7.3.1.4 Asia Pacific Others Market, by Country
    • 7.3.2 Asia Pacific Cell Penetrating Peptide Market, by Application
      • 7.3.2.1 Asia Pacific Drug Delivery Market, by Country
      • 7.3.2.2 Asia Pacific Gene Delivery Market, by Country
      • 7.3.2.3 Asia Pacific Diagnostics Market, by Country
      • 7.3.2.4 Asia Pacific Molecular Imaging Market, by Country
      • 7.3.2.5 Asia Pacific Others Market, by Country
    • 7.3.3 Asia Pacific Cell Penetrating Peptide Market, by Type
      • 7.3.3.1 Asia Pacific Synthetic CPPs Market, by Country
      • 7.3.3.2 Asia Pacific Protein-derived CPPs Market, by Country
      • 7.3.3.3 Asia Pacific Chimeric CPPs Market, by Country
    • 7.3.4 Asia Pacific Cell Penetrating Peptide Market, by Country
      • 7.3.4.1 China Cell Penetrating Peptide Market
        • 7.3.4.1.1 China Cell Penetrating Peptide Market, by End-use
        • 7.3.4.1.2 China Cell Penetrating Peptide Market, by Application
        • 7.3.4.1.3 China Cell Penetrating Peptide Market, by Type
      • 7.3.4.2 Japan Cell Penetrating Peptide Market
        • 7.3.4.2.1 Japan Cell Penetrating Peptide Market, by End-use
        • 7.3.4.2.2 Japan Cell Penetrating Peptide Market, by Application
        • 7.3.4.2.3 Japan Cell Penetrating Peptide Market, by Type
      • 7.3.4.3 India Cell Penetrating Peptide Market
        • 7.3.4.3.1 India Cell Penetrating Peptide Market, by End-use
        • 7.3.4.3.2 India Cell Penetrating Peptide Market, by Application
        • 7.3.4.3.3 India Cell Penetrating Peptide Market, by Type
      • 7.3.4.4 South Korea Cell Penetrating Peptide Market
        • 7.3.4.4.1 South Korea Cell Penetrating Peptide Market, by End-use
        • 7.3.4.4.2 South Korea Cell Penetrating Peptide Market, by Application
        • 7.3.4.4.3 South Korea Cell Penetrating Peptide Market, by Type
      • 7.3.4.5 Taiwan Cell Penetrating Peptide Market
        • 7.3.4.5.1 Taiwan Cell Penetrating Peptide Market, by End-use
        • 7.3.4.5.2 Taiwan Cell Penetrating Peptide Market, by Application
        • 7.3.4.5.3 Taiwan Cell Penetrating Peptide Market, by Type
      • 7.3.4.6 Malaysia Cell Penetrating Peptide Market
        • 7.3.4.6.1 Malaysia Cell Penetrating Peptide Market, by End-use
        • 7.3.4.6.2 Malaysia Cell Penetrating Peptide Market, by Application
        • 7.3.4.6.3 Malaysia Cell Penetrating Peptide Market, by Type
      • 7.3.4.7 Rest of Asia Pacific Cell Penetrating Peptide Market
        • 7.3.4.7.1 Rest of Asia Pacific Cell Penetrating Peptide Market, by End-use
        • 7.3.4.7.2 Rest of Asia Pacific Cell Penetrating Peptide Market, by Application
        • 7.3.4.7.3 Rest of Asia Pacific Cell Penetrating Peptide Market, by Type
  • 7.4 LAMEA Cell Penetrating Peptide Market
    • 7.4.1 LAMEA Cell Penetrating Peptide Market, by End-use
      • 7.4.1.1 LAMEA Pharmaceutical and Biotechnology Companies Market, by Country
      • 7.4.1.2 LAMEA Contract Research Organization (CROs) Market, by Country
      • 7.4.1.3 LAMEA Hospitals & Clinics Market, by Country
      • 7.4.1.4 LAMEA Others Market, by Country
    • 7.4.2 LAMEA Cell Penetrating Peptide Market, by Application
      • 7.4.2.1 LAMEA Drug Delivery Market, by Country
      • 7.4.2.2 LAMEA Gene Delivery Market, by Country
      • 7.4.2.3 LAMEA Diagnostics Market, by Country
      • 7.4.2.4 LAMEA Molecular Imaging Market, by Country
      • 7.4.2.5 LAMEA Others Market, by Country
    • 7.4.3 LAMEA Cell Penetrating Peptide Market, by Type
      • 7.4.3.1 LAMEA Synthetic CPPs Market, by Country
      • 7.4.3.2 LAMEA Protein-derived CPPs Market, by Country
      • 7.4.3.3 LAMEA Chimeric CPPs Market, by Country
    • 7.4.4 LAMEA Cell Penetrating Peptide Market, by Country
      • 7.4.4.1 Brazil Cell Penetrating Peptide Market
        • 7.4.4.1.1 Brazil Cell Penetrating Peptide Market, by End-use
        • 7.4.4.1.2 Brazil Cell Penetrating Peptide Market, by Application
        • 7.4.4.1.3 Brazil Cell Penetrating Peptide Market, by Type
      • 7.4.4.2 Argentina Cell Penetrating Peptide Market
        • 7.4.4.2.1 Argentina Cell Penetrating Peptide Market, by End-use
        • 7.4.4.2.2 Argentina Cell Penetrating Peptide Market, by Application
        • 7.4.4.2.3 Argentina Cell Penetrating Peptide Market, by Type
      • 7.4.4.3 UAE Cell Penetrating Peptide Market
        • 7.4.4.3.1 UAE Cell Penetrating Peptide Market, by End-use
        • 7.4.4.3.2 UAE Cell Penetrating Peptide Market, by Application
        • 7.4.4.3.3 UAE Cell Penetrating Peptide Market, by Type
      • 7.4.4.4 Saudi Arabia Cell Penetrating Peptide Market
        • 7.4.4.4.1 Saudi Arabia Cell Penetrating Peptide Market, by End-use
        • 7.4.4.4.2 Saudi Arabia Cell Penetrating Peptide Market, by Application
        • 7.4.4.4.3 Saudi Arabia Cell Penetrating Peptide Market, by Type
      • 7.4.4.5 South Africa Cell Penetrating Peptide Market
        • 7.4.4.5.1 South Africa Cell Penetrating Peptide Market, by End-use
        • 7.4.4.5.2 South Africa Cell Penetrating Peptide Market, by Application
        • 7.4.4.5.3 South Africa Cell Penetrating Peptide Market, by Type
      • 7.4.4.6 Nigeria Cell Penetrating Peptide Market
        • 7.4.4.6.1 Nigeria Cell Penetrating Peptide Market, by End-use
        • 7.4.4.6.2 Nigeria Cell Penetrating Peptide Market, by Application
        • 7.4.4.6.3 Nigeria Cell Penetrating Peptide Market, by Type
      • 7.4.4.7 Rest of LAMEA Cell Penetrating Peptide Market
        • 7.4.4.7.1 Rest of LAMEA Cell Penetrating Peptide Market, by End-use
        • 7.4.4.7.2 Rest of LAMEA Cell Penetrating Peptide Market, by Application
        • 7.4.4.7.3 Rest of LAMEA Cell Penetrating Peptide Market, by Type

Chapter 8. Company Profiles

  • 8.1 Biosynth Ltd
    • 8.1.1 Company Overview
    • 8.1.2 SWOT Analysis
  • 8.2 Creative Peptides
    • 8.2.1 Company Overview
    • 8.2.2 SWOT Analysis
  • 8.3 Cupid Peptide Company Limited
    • 8.3.1 Company Overview
    • 8.3.2 SWOT Analysis
  • 8.4 Alta Bioscience Ltd
    • 8.4.1 Company Overview
    • 8.4.2 SWOT Analysis
  • 8.5 AnaSpec Inc. (Kaneka Eurogentec S.A.) (Kaneka Corporation)
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 SWOT Analysis
  • 8.6 Peptomyc SL
    • 8.6.1 Company Overview
    • 8.6.2 SWOT Analysis
  • 8.7 PolyPeptide Group AG
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 SWOT Analysis
  • 8.8 Bachem Holding AG (Ingro Finanz AG)
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 SWOT Analysis
  • 8.9 Sarepta Therapeutics, Inc.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Research & Development Expenses
  • 8.10. Revance Therapeutics, Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental Analysis
    • 8.10.4 Research & Development Expenses
    • 8.10.5 SWOT Analysis

Chapter 9. Winning Imperatives of Cell Penetrating Peptide Market